Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s): ACHFF

Technology Scientific & Technical Instruments

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

Add To Watchlist

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > Interesting article

View:

Post by Viking2233 on Aug 18, 2024 7:14pm

Interesting article

The article below might support my theory regarding Canadian sites obtaining final approvals to participate in our phase 2 AKI trial.

All I can say is we should be thankful we are doing in Turkey.

It looks great on paper to have these prestigious Canadian sites wanting to participate but the reality is the approval process works against what is best for Canadians who are out of options.

https://www.theglobeandmail.com/business/adv/article-shortening-the-regulatory-timeline-will-benefit-patients-and-the/

My excitement of when I saw the news release about the 3 Canadian sites wanting to participate in this trial has fizzled out.

205